XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · IEX Real-Time Price · USD
2.810
+0.110 (4.07%)
At close: Mar 28, 2024, 4:00 PM
2.720
-0.090 (-3.20%)
After-hours: Mar 28, 2024, 7:47 PM EDT
Total Valuation
XTLB has a market cap or net worth of $15.82 million. The enterprise value is $12.09 million.
Market Cap | 15.82M |
Enterprise Value | 12.09M |
Important Dates
The last earnings date was Thursday, November 1, 2018, before market open.
Earnings Date | Nov 1, 2018 |
Ex-Dividend Date | n/a |
Share Statistics
XTLB has 6.37 million shares outstanding.
Shares Outstanding | 6.37M |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 4.55% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.95 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -28.90% and return on invested capital (ROIC) is -22.01%.
Return on Equity (ROE) | -28.90% |
Return on Assets (ROA) | -25.00% |
Return on Capital (ROIC) | -22.01% |
Revenue Per Employee | n/a |
Profits Per Employee | -$168,500 |
Employee Count | 8 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +117.83% in the last 52 weeks. The beta is 0.79, so XTLB's price volatility has been lower than the market average.
Beta (1Y) | 0.79 |
52-Week Price Change | +117.83% |
50-Day Moving Average | 1.15 |
200-Day Moving Average | 1.01 |
Relative Strength Index (RSI) | 77.29 |
Average Volume (30 Days) | 738,363 |
Short Selling Information
Short Interest | 2,001 |
Short Previous Month | 1,793 |
Short % of Shares Out | 1.02% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.89 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -880,000 |
Pretax Income | -1.35M |
Net Income | -1.35M |
EBITDA | -1.35M |
EBIT | -1.35M |
Earnings Per Share (EPS) | -$0.20 |
Balance Sheet
The company has $3.72 million in cash and no debt, giving a net cash position of $3.72 million or $0.58 per share.
Cash & Cash Equivalents | 3.72M |
Total Debt | n/a |
Net Cash | 3.72M |
Net Cash Per Share | $0.58 |
Equity / Book Value | 4.00M |
Book Value Per Share | 0.63 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | -901,000 |
Capital Expenditures | n/a |
Free Cash Flow | -901,000 |
FCF Per Share | -$0.17 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
XTLB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 11.48% |
Shareholder Yield | 11.48% |
Earnings Yield | -8.52% |
FCF Yield | -5.70% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 10, 2017. It was a reverse split with a ratio of 1:5.
Last Split Date | Feb 10, 2017 |
Split Type | Reverse |
Split Ratio | 1:5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |